DD132433A5 - Verfahren zur herstellung neuer 0-(3-amino-2-hydroxypropyl)-amidoxim-derivate - Google Patents
Verfahren zur herstellung neuer 0-(3-amino-2-hydroxypropyl)-amidoxim-derivateInfo
- Publication number
- DD132433A5 DD132433A5 DD7700200719A DD20071977A DD132433A5 DD 132433 A5 DD132433 A5 DD 132433A5 DD 7700200719 A DD7700200719 A DD 7700200719A DD 20071977 A DD20071977 A DD 20071977A DD 132433 A5 DD132433 A5 DD 132433A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- amidoxim
- hydroxypropyl
- derivatives
- amino
- producing new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU76CI1682A HU177578B (en) | 1976-08-27 | 1976-08-27 | Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DD132433A5 true DD132433A5 (de) | 1978-09-27 |
Family
ID=10994625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD7700200719A DD132433A5 (de) | 1976-08-27 | 1977-08-24 | Verfahren zur herstellung neuer 0-(3-amino-2-hydroxypropyl)-amidoxim-derivate |
Country Status (23)
Country | Link |
---|---|
JP (1) | JPS5350131A (sv) |
AT (1) | AT355554B (sv) |
AU (1) | AU521432B2 (sv) |
BE (1) | BE858134A (sv) |
CA (1) | CA1077506A (sv) |
CH (1) | CH630344A5 (sv) |
CS (1) | CS204008B2 (sv) |
DD (1) | DD132433A5 (sv) |
DE (1) | DE2738589A1 (sv) |
DK (1) | DK150196C (sv) |
ES (1) | ES462346A1 (sv) |
FI (1) | FI68396C (sv) |
FR (1) | FR2362845A1 (sv) |
GB (1) | GB1582029A (sv) |
GR (1) | GR63623B (sv) |
HU (1) | HU177578B (sv) |
IL (1) | IL52804A (sv) |
NL (1) | NL187478C (sv) |
NO (1) | NO144793C (sv) |
PL (1) | PL107628B1 (sv) |
SE (1) | SE435280B (sv) |
SU (1) | SU730296A3 (sv) |
YU (2) | YU202377A (sv) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4849522A (en) * | 1983-11-03 | 1989-07-18 | Merrell Dow Pharmaceuticals | Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones |
ZA848428B (en) * | 1983-11-03 | 1985-06-26 | Merrell Pharma Inc | Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones |
US5212314A (en) * | 1983-11-03 | 1993-05-18 | Merrell Dow Pharmaceuticals Inc. | Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones |
JPH01169445A (ja) * | 1987-12-25 | 1989-07-04 | Fuji Photo Film Co Ltd | 焦点距離切換えカメラ |
HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
HUT54347A (en) * | 1989-01-10 | 1991-02-28 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoximes |
HU222994B1 (hu) * | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
HUT78139A (hu) * | 1995-12-22 | 2000-11-28 | BIOREX Kutató és Fejlesztő Rt. | Készítmény, különösen a bőr öregedési folyamatainak mérséklésére |
ATE272625T1 (de) | 1998-05-11 | 2004-08-15 | Takeda Chemical Industries Ltd | Oxyiminoalkansäure derivate mit hypoglykämischer und hypolipidemischer wirkung |
AU5296799A (en) * | 1998-08-03 | 2000-02-28 | N-Gene Kutato Kft. | Pharmaceutical compositions against autoimmune diseases |
KR20040089102A (ko) | 2002-01-11 | 2004-10-20 | 비오렉스 쿠타토 에쉬 훼레스테 에르테 | 카르복사미딘 유도체 및 혈관 질환의 치료에서의 이들 용도 |
HUP0303584A3 (en) | 2003-10-30 | 2009-12-28 | Cytrx Corp | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
IL303026A (en) | 2020-11-19 | 2023-07-01 | Zevra Denmark As | Processes for preparing arimoclomol citrate and its intermediates |
-
1976
- 1976-08-27 HU HU76CI1682A patent/HU177578B/hu unknown
-
1977
- 1977-08-22 AT AT605477A patent/AT355554B/de not_active IP Right Cessation
- 1977-08-23 SE SE7709482A patent/SE435280B/sv not_active IP Right Cessation
- 1977-08-23 NL NLAANVRAGE7709276,A patent/NL187478C/xx not_active IP Right Cessation
- 1977-08-23 IL IL7752804A patent/IL52804A/xx unknown
- 1977-08-24 DD DD7700200719A patent/DD132433A5/xx unknown
- 1977-08-24 CS CS775551A patent/CS204008B2/cs unknown
- 1977-08-24 GR GR54222A patent/GR63623B/el unknown
- 1977-08-25 YU YU02023/77A patent/YU202377A/xx unknown
- 1977-08-25 GB GB35745/77A patent/GB1582029A/en not_active Expired
- 1977-08-26 NO NO772958A patent/NO144793C/no unknown
- 1977-08-26 CH CH1047377A patent/CH630344A5/de not_active IP Right Cessation
- 1977-08-26 FR FR7726070A patent/FR2362845A1/fr active Granted
- 1977-08-26 DK DK379777A patent/DK150196C/da not_active IP Right Cessation
- 1977-08-26 BE BE180447A patent/BE858134A/xx not_active IP Right Cessation
- 1977-08-26 DE DE19772738589 patent/DE2738589A1/de active Granted
- 1977-08-26 JP JP10250477A patent/JPS5350131A/ja active Granted
- 1977-08-26 SU SU772514754A patent/SU730296A3/ru active
- 1977-08-26 PL PL1977206476A patent/PL107628B1/pl unknown
- 1977-08-26 CA CA285,529A patent/CA1077506A/en not_active Expired
- 1977-08-26 FI FI772551A patent/FI68396C/fi not_active IP Right Cessation
- 1977-08-26 AU AU28254/77A patent/AU521432B2/en not_active Expired
- 1977-09-08 ES ES77462346A patent/ES462346A1/es not_active Expired
-
1982
- 1982-10-22 YU YU02377/82A patent/YU237782A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2825477A (en) | 1979-03-01 |
JPS6216942B2 (sv) | 1987-04-15 |
JPS5350131A (en) | 1978-05-08 |
DK150196C (da) | 1987-07-06 |
CS204008B2 (en) | 1981-03-31 |
PL107628B1 (pl) | 1980-02-29 |
DK150196B (da) | 1987-01-05 |
HU177578B (en) | 1981-11-28 |
FI772551A (fi) | 1978-02-28 |
CH630344A5 (en) | 1982-06-15 |
GB1582029A (en) | 1980-12-31 |
FI68396B (fi) | 1985-05-31 |
SU730296A3 (ru) | 1980-04-25 |
ATA605477A (de) | 1979-08-15 |
YU237782A (en) | 1983-12-31 |
FR2362845A1 (fr) | 1978-03-24 |
IL52804A0 (en) | 1977-10-31 |
NO772958L (no) | 1978-02-28 |
NL187478C (nl) | 1991-10-16 |
IL52804A (en) | 1981-06-29 |
DK379777A (da) | 1978-02-28 |
YU202377A (en) | 1983-12-31 |
NO144793B (no) | 1981-08-03 |
NO144793C (no) | 1981-11-11 |
BE858134A (fr) | 1977-12-16 |
SE7709482L (sv) | 1978-02-28 |
SE435280B (sv) | 1984-09-17 |
CA1077506A (en) | 1980-05-13 |
NL7709276A (nl) | 1978-03-01 |
FR2362845B1 (sv) | 1981-01-09 |
FI68396C (fi) | 1985-09-10 |
ES462346A1 (es) | 1978-06-16 |
AU521432B2 (en) | 1982-04-01 |
DE2738589A1 (de) | 1978-03-02 |
AT355554B (de) | 1980-03-10 |
GR63623B (en) | 1979-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT366361B (de) | Verfahren zur herstellung neuer 2-aminotetraline | |
AT371817B (de) | Verfahren zur herstellung neuer ergolinderivate | |
AT362364B (de) | Verfahren zur herstellung neuer phenylimi- dazolidinonderivate | |
AT371139B (de) | Verfahren zur herstellung neuer bitumenzusammen- setzungen | |
AT351510B (de) | Verfahren zur herstellung neuer substituierter fluoracylresorcine | |
DD132433A5 (de) | Verfahren zur herstellung neuer 0-(3-amino-2-hydroxypropyl)-amidoxim-derivate | |
ATA60577A (de) | Verfahren zur herstellung neuer polypeptidderivate | |
ATA151981A (de) | Verfahren zur herstellung neuer benzopyranderivate | |
AT352918B (de) | Verfahren zur herstellung neuer histidin- derivate | |
DD132438A5 (de) | Verfahren zur herstellung neuer kortikoide | |
AT362389B (de) | Verfahren zur herstellung neuer nitrosoharn- stoff-derivate | |
AT351673B (de) | Verfahren zur herstellung neuer antibiotika | |
AT351046B (de) | Verfahren zur herstellung neuer diharnstoffe | |
ATA736576A (de) | Verfahren zur herstellung neuer indolderivate | |
AT360971B (de) | Verfahren zur herstellung neuer alkinole | |
DD131169A5 (de) | Verfahren zur herstellung neuer azatetracyclen | |
AT367767B (de) | Verfahren zur herstellung neuer ergopeptidalkaloidderivate | |
AT372386B (de) | Verfahren zur herstellung neuer ergopeptidalkaloidderivate | |
AT348162B (de) | Verfahren zur herstellung neuer d-homosteroide | |
AT355239B (de) | Verfahren zur herstellung neuer d-homosteroide | |
ATA947076A (de) | Verfahren zur herstellung neuer ergolinderivate | |
ATA590279A (de) | Verfahren zur herstellung neuer 2-aminotetraline | |
ATA797079A (de) | Verfahren zur herstellung neuer kortikoide | |
ATA797179A (de) | Verfahren zur herstellung neuer kortikoide | |
AT341531B (de) | Verfahren zur herstellung neuer octahydropyridoindolobenzazepine |